Scope of Submission
We welcome submissions from a broad range of disciplines, including but not limited to:
- Designing effective clinical trials in hematology
- Ethical considerations in clinical research
- Patient recruitment strategies for trials
- Innovative endpoints in hematology trials
- Long-term follow-up in clinical trials
- Impact of trial results on clinical practice
- Collaboration between researchers and clinicians
- Regulatory challenges in clinical trials
- Global perspectives on clinical trial methodologies
- Technological advancements in trial monitoring
- Patient-centered outcomes in clinical research
- Case studies in successful hematology trials
- Challenges in rare disease clinical trials
- Role of biomarkers in clinical trials
- Future directions in hematology clinical research
- Impact of COVID-19 on clinical trials
- Education and training for clinical researchers
- Innovations in trial design and methodology
- Psychosocial aspects of participating in trials
- Impact of trial results on patient care
All papers must be original and not previously published or submitted elsewhere.